SITAGLO MP 1S (Metformin (1000mg) + Pioglitazone (15mg) + Sitagliptin (100mg))

Sitaglo MP 1000 mg Tablet 10’s is classified as an anti-diabetic medication utilized in the management of type 2 diabetes mellitus. This medical condition is characterized by elevated blood glucose levels, primarily due to the body’s inadequate production of insulin or ineffective use of this hormone. The formulation of Sitaglo MP includes three active ingredients: Metformin, Pioglitazone, and Sitagliptin. These agents collaborate to enhance the body’s sensitivity to insulin while simultaneously reducing the hepatic production of glucose and limiting the absorption of sugars from dietary sources. As a result, this combination therapy aids in the effective regulation of blood sugar concentrations. While Sitaglo MP is generally well-tolerated, it may occasionally lead to adverse effects such as nausea, gastrointestinal discomfort, diarrhea, and headaches in some individuals. These side effects are usually mild and may dissipate over time without the need for medical intervention. However, should any side effects persist or intensify, it is advisable to seek medical advice. It is crucial to avoid using Sitaglo MP if there is a known allergy to any of its components. Patients are encouraged to keep their healthcare provider informed about their overall health status and any other medications being taken to prevent potential interactions or complications.